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The effect of metabolic stress on the bone marrow
microenvironment is poorly defined. We show that
high-fat diet (HFD) decreased long-term LinSca-
1+c-Kit+ (LSK) stem cells and shifted lymphoid to
myeloid cell differentiation. Bonemarrow niche func-
tion was impaired after HFD as shown by poor recon-
stitution of hematopoietic stem cells. HFD led to
robust activation of PPARg2, which impaired osteo-
blastogenesis while enhancing bone marrow adipo-
genesis. At the same time, expression of genes
such as Jag-1, SDF-1, and IL-7 forming the bone
marrow niche was highly suppressed after HFD.
Moreover, structural changes of microbiota were
associated to HFD-induced bone marrow changes.
Antibiotic treatment partially rescued HFD-mediated
effects on the bone marrow niche, while transplanta-
tion of stools from HFD mice could transfer the
effect to normal mice. These findings show that
metabolic stress affects the bone marrow niche by
alterations of gut microbiota and osteoblast-adipo-
cyte homeostasis.
INTRODUCTION
Obesity has become a worldwide health problem (Kopelman,
2000). It is considered as an inflammatory state per se and in-
creases the risk of diabetes, atherosclerosis, and musculoskel-
etal disease including arthritis and bone disease (Abou-Raya
and Abou-Raya, 2006). Obesity is therefore associated with pre-
mature death and reduced life quality. Themolecular and cellular
mechanisms explaining how obesity negatively affects the func-
tion of multiple organs are not fully understood. Changes in the
function of the hematopoietic and immune cell compartment
are an attractive concept to explain the deleterious effects
of obesity on organ function (Nagareddy et al., 2014). The
modifications of the microbiome in obese people affect their
fat metabolism (Devaraj et al., 2013) and therefore maymodulate
functional properties of the hematopoietic system and the im-
mune cell function in tissues (Khosravi et al., 2014).886 Cell Metabolism 22, 886–894, November 3, 2015 ª2015 ElsevierCommunication between the mesenchymal tissue and the
hematopoietic system primarily occurs in the bone marrow
(BM), where bone forms a niche based on mesenchymal cells
for the developing blood and immune cells (Frenette et al.,
2013). On the bone surface, CXCL12-abundant reticular (CAR)
cells, spindle-shaped N-cadherin+CD45 osteoblastic (SNO)
cells, and osteoblasts (OBLs) form a specific niche, which pro-
vides a suitable microenvironment for supporting hematopoietic
stem cell (HSC) development and activation (Calvi et al., 2003;
Zhang et al., 2003). The OBL lineage is a population derived
from mesenchymal stem cells (MSCs), which is essential for
bone homeostasis and HSC mobilization and homing by
secreting osteopontin (OPN) and stromal-derived factor-1
(SDF-1) (Lapidot et al., 2005; Stier et al., 2005). In addition,
the endosteal HSC niche mainly formed by OBLs also regulates
HSC quiescence or expansion through the signaling of angio-
poietin-1 (Ang-1)/Tie2 and Jagged-1 (Jag-1)/Notch (Arai et al.,
2004; Calvi et al., 2003). The properties of the endosteal HSC
and immune cell niche may therefore essentially depend on
the differentiation status of MSC (Luu et al., 2009), which can
be altered during obesity. Indeed, high-fat diet (HFD) exposure
has been shown to affect hematopoiesis (Singer et al., 2014;
Trottier et al., 2012). However, how exposure to HFD affects
the HSC compartment and bone-derived niches is yet to be
determined.
To address the effects of obesity on the HSC niche, we set up
a short-term diet-induced obesity and performed a detailed
analysis of the cells and molecules involved in the HSC niche
formation. Considering that obesity may primarily modulate the
differentiation of mesenchymal cells, which in turn alters the
HSC niches, we studied the cellular and molecular changes
of hematopoietic and mesenchymal lineage cells in the BM
after exposure to HFD. Furthermore, we determined that micro-
biota altered by HFD influenced the hematopoietic and immune
cell lineages, pointing to new strategies to interfere with this
process.RESULTS
HFD Exposure Led to HSC Pool Expansion with a Shift
from Lymphoid to Myeloid Lineage
C57BL/6 mice were fed with HFD or normal diet (ND) to evaluate
the impact of HFD exposure on theHSCpopulation. BodyweightInc.
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and body mass index were significantly increased 6 weeks after
HFD exposure (Figures S1A and S1B). Although BM cellularity
was not significantly different between ND and HFD mice (Fig-
ure S1C), the percentage and absolute number of HSC, defined
as LinSca-1+c-Kit+ (LSK), were significantly higher in mice
receiving 2 weeks of HFD than those receiving ND (Figure 1A,
Figure S1D). Colony-forming units were increased on day 14 in
the culture from HFD mice compared to ND mice (Figure S1E).
In addition, quantification of the LSK sub-population including
long-termHSCs (LT-LSK), short-termHSCs (ST-LSK), andmulti-
potent progenitors (MPP) showed decreased percentage of LT-
LSK, whereas the percentage and absolute number ofMPPwere
increased in the HFD mice compared to ND. No difference was
detected for the ST-LSK population (Figure 1B, Figure S1D).
These data suggest that increased LSK pool might be due to
an alteration of proliferation or cell cycle of HSCs. Indeed, LSK
cells displayed an increased BrdU incorporation on day 14 under
HFD (Figure S1F). Meanwhile, an increased proportion of LSK
entering into G1 phase was observed on day 3 and into S/G2/
M phase on day 14 in HFD mice (Figure S1G). These data indi-
cated that HFD led to an increased HSC pool, which was attrib-
uted to an expansion of the progenitor compartment at the
expense of LT-HSCs.
To determine if the increased HSC progenitor cells conse-
quently induces a change in the pattern of hematopoietic differ-
entiation, common lymphoid progenitor (CLP), commonmyeloid
progenitor (CMP), megakaryocyte/erythrocyte progenitor (MEP),
and granulocyte/monocyte progenitor (GMP) percentages
and absolute numbers were quantified. Interestingly, a shift to
increased CMP was observed in HFD mice BM compared to
ND, whereas CLP were decreased (Figure 1C, Figure S1D).
Moreover, CLP population was increased in blood of HFD
mice, and LSK and myeloid progenitors were decreased
in spleen (Figure S1H), suggesting that HFD contributes to
HSC mobilization into peripheral blood. In addition, B220+ and
B220+IgM+IgD populations were also significantly reduced in
BM from HFD mice, consistent with the decreased frequency
of CLP (Figures 1D–1F). Three weeks of normal diet reversed
the HFD LSK phenotype (data not shown). Moreover, BM trans-
fer experiments demonstrated that there is identical repopula-
tion activity of BM from HFD (CD45.2) and ND (CD45.1) mice in
ND mice, suggesting that HFD essentially induces changes in
the BM microenvironment (data not shown). Collectively, these
data suggested that HFD affects the differentiation pattern of
the hematopoietic lineage toward the myeloid lineage at the
expense of the lymphoid lineage.
HFD Treated Mice Failed Hematologic Recovery in a
Hematologic Stress Condition
We next addressed whether the HFD-induced HSC pool alter-
ations have any functional consequences. Therefore, ND and
HFD mice were challenged with the myelo-suppressive agentFigure 1. Hematopoietic Stem Cell and Myeloid Lineage Were Disturb
(A) FACS quantification of LSK in BM from mice receiving HFD or ND for 1, 2, or
(B) FACS quantification of LT-LSK, ST-LSK, and MPP cells in BM from mice rec
(C and D) FACS quantification of myeloid progenitor, CMP, CLP, GMP, MEP (C),
(E and F) FACS plot (E) and absolute numbers (F) of B cell and B cell progenitors
See also Figure S1. Data represent the mean ± SEM. *p < 0.05, **p < 0.01 were
888 Cell Metabolism 22, 886–894, November 3, 2015 ª2015 Elsevier5-fluorouracil (5-FU), known to reduce both myeloid and
lymphoid compartments (Harrison and Lerner, 1991). As ex-
pected, BM cellularity was dramatically reduced after 5-FU in-
jection and remained low in the two groups until day 3. However,
a significantly faster recovery of cellularity was observed in ND
mice compared to HFD. Surprisingly, despite the higher baseline
percentage of LSK, HFD mice displayed a lower recovered pro-
portion of LSK cells in BM compared to ND mice (Figure S1I),
without detectable cell survival difference (data not shown).
Similarly, myeloid progenitor recovery was lower in HFD mice
compared to ND (Figure S1I). Inflammation is probably not
involved in HSC expansion caused by HFD, since no difference
in BM cytokine levels between HFD and NDwere found (data not
shown). Together these data suggested that HFD mice failed to
recover their HSC compartment and in consequence showed
impaired hematologic regeneration.
HFD Altered the HSC Niche and Bone Architecture
Since BM cells from ND or HFD mice equally repopulate normal
BM, we hypothesized that the bone architecture and BM micro-
environment was disturbed following HFD. Therefore, bone
architecture was analyzed by micro-computed tomography
(microCT), revealing a decreased bone volume and trabecular
number in HFD mice compared to ND mice (Figures S1J and
S1K). The decreased bone volume was not due to osteoclast
(Oc) alteration, since neither Oc surface, Oc number, or Oc
gene expression was modified in HFD compared to ND mice
(Figures S1L and S1M). Interestingly, histomorphometric quanti-
fication showed that OBL number was decreased whereas
adipocyte number was strongly increased in long bones of
HFD-exposedmice (Figures 2A and 2B). To confirm and visualize
the differences in BM fat content, MRI analysis was performed.
T1 relaxivity in BM from HFD mice was decreased, confirming
the increased number of adipocytes (Figure 2C, Figure S1N).
The levels of osteoblastic markers such as Runt-related tran-
scription factor 2 (Runx2), osterix, collagen I alpha 1 (col1a1),
and osteocalcin mRNA were reduced in flushed bone after
HFD exposure, confirming the defect in OBL (Figure S1O).
Despite no change in Cebp/b and aP2 gene expression, leptin
was significantly increased in CD45 BM cells of HFD mice
(Figure S1P).
Since MSCs are precursor cells for OBLs, adipocytes, and
CAR cells, we quantified them as Ter119CD45Sca-1+ cells.
Surprisingly, a significant increase in the proportion of MSCs
was detected in BM from HFD mice compared to ND mice (Fig-
ure 2D). Next, we quantified CAR as SDF-1+ and Nestin+ MSC
cell, known to be important for the maintenance of HSC (Me´n-
dez-Ferrer et al., 2010). Immunofluorescence staining of SDF-1
showed a decreased number of SDF-1+ cells in the endosteal
niche and BM of HFD mice (Figure 2E), whereas Nestin+ MSC
was significantly increased in HFD mouse BM compared with
ND (Figure 2F). To confirm that the cellular modification alsoed after 6 Weeks of HFD
6 weeks.
eiving HFD (n = 8) or ND (n = 10) for 6 weeks.
and B cell (D) in BM from mice receiving HFD or ND for 1, 2, or 6 weeks (n = 6).
in BM from mice receiving HFD (n = 8) or ND (n = 6) for 6 weeks.
assessed using Student’s t test.
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Figure 2. Deregulation of the Bone Architecture and BM Niches by HFD Exposure
(A) Hematoxylin and eosin (H&E) and Toluidine blue (T.B) staining (magnification 103) of tibia from mice receiving HFD or ND for 6 weeks.
(B) Histomorphometric quantification of osteoblast number per trabecular area (N.Obs/T.Ar), osteoblast surface per bone surface (Ob.S/BS), and adipocyte
number per trabecular area (N.Adipos/T.Ar) in the tibia of mice receiving HFD or ND for 6 weeks (n = 6).
(C) MRI analyses of long bones from mice under HFD and ND for 6 weeks revealed decreased values for T1 relaxivity in HFD BM (arrows, BM).
(D) FACS quantification of MSC in BM from mice receiving HFD (n = 8) or ND (n = 10) for 6 weeks.
(E) Immunofluorescence staining for SDF-1 in bone (magnification 403). Arrows indicate SDF-1-positive cells. Quantification of SDF-1 positive cells in BM from
HFD or ND mice.
(legend continued on next page)
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leads to molecular signaling defects, we assessed the molecular
profile of genes implicated in the HSC niche. Whereas no signif-
icant difference of the expression of C-X-C chemokine receptor
type 4 (cxcr4), Ang-1, and stem cell factor (SCF) was observed
between the two groups, the expression of Jag-1,OPN, vascular
cell adhesion protein 1 (vcam1), Notch2, Tie2, IL-7, and SDF-1
were significantly decreased in long bone of HFD mice
compared to ND (Figure 2G). The known function of PPAR
isoforms in bone homeostasis prompted us to analyze their
gene expression (Scholtysek et al., 2013). PPARa and PPARg2
mRNA levels were increased in CD45 BM cells from HFD
mice (Figure 2H). Hence, HFD effectively impaired the BM niche
function by decreasing the osteoblastic but increasing the
adipocyte lineage.
PPARg Inhibition Rescued the HSC Niche Alteration
Induced by HFD
To test at the cellular level if BM adipocytes are responsible for
the HSC niche defect, we intraperitoneally injected Bisphenol-
A diglycidylether (BADGE), a PPARg inhibitor, to HFD and ND
mice for 2 weeks (Figure S2A). Indeed, BADGE treatment
decreased PPARg2 mRNA level in BM of both ND and HFD
groups (Figure S2B) and rescued bone volume, trabecular num-
ber, and thickness as well as the numbers of OBLs and adipo-
cytes (Figure S2C). There were no significant alterations of
growth factor or cytokine levels in the BM of both groups (Fig-
ure S2D). Leptin level in BM was also rescued by BADGE
treatment (Figure S2E). MSC populations was comparable in
BADGE-treated ND or HFD mice (Figure S2F). Furthermore,
FACS analyses showed that LSK, LT-LSK, ST-LSK, MPP,
CLP, and B220+IgM+IgD cells number were comparable in
BADGE-treated HFD and ND mouse BM (Figures S2G–S2I).
This rescue was accompanied by a normalization of Jag-1,
Notch1, Notch2, Tie2, and SDF-1 (Figure S2J), suggesting that
2-week inhibition of PPARg by BADGE is sufficient to rescue
the endosteal bone niche and HSC development of HFD mice
by regulating MSC differentiation.
Altered GutMicrobiota by HFDRegulate HSC Population
Emerging evidence has indicated that gut microbiota influence
HSC and immune cell homeostasis (Khosravi et al., 2014).
Indeed, as shown by next-generation sequencing (Figures 3A
and 3B), HFD resulted in markedly diverse gut microbial com-
munities in cecum and ileum compared to control mice. As in
humans, > 90% of bacterial phylogenetic types (phylotypes)
comprising the mouse distal gut microbiota are members of
two major bacterial divisions (phyla): the Bacteroidetes and
the Firmicutes (Turnbaugh et al., 2008). Analyses of the micro-
biota at the phylum level indicated a dominance of Bacteroi-
detes and Firmicutes in ND mice (Figures 3A and 3B). However,
the proportions of these two populations were decreased in
HFD mice, whereas the levels of Verrucomicrobia, Actinobacte-
ria, and Proteobacteria were increased in cecum and ileum of
HFD mice (Figure 3B). These results, along with the data of(F) FACS quantification of Nestin+ MSCs in BM from mice receiving HFD or ND f
(G and H) Real-time PCR analysis for BM niche markers (G) in long bone and PPA
(n = 6).
Data represent the mean ± SEM. See also Figures S1 and S2. *p < 0.05, **p < 0.
890 Cell Metabolism 22, 886–894, November 3, 2015 ª2015 ElsevierHSC alterations in HFD mice raised the question whether mi-
crobiota from HFD mice could potentially regulate the HSC
population.
HFD Microbiota Transferred the Alterations of the HSC
Niche
To address this question, we transferred ND or HFD microbiota
from cecum and ileum into ND mice (Figure S3A). Interestingly,
LSK andMPP populations were significantly increased, whereas
LT-LSK was decreased in BM of mice receiving HFD microbiota
(Figures 3C and 3D). Moreover, HFD microbiota transplantation
also led to an increased myeloid progenitor population and a
decreased CLP population in BM (Figure 3E), similar to HFD
mice. In addition, mice receiving HFD microbiota showed an
increased percentage of MSC (Figure 3F). Consistently,
decreased expression of Ang-1, SDF-1, and Notch1 and 2 and
increased expression of KitL was observed in mice receiving
HFD microbiota (Figure S3B). Interestingly, HFD microbiota
transplantation led to a decrease of OBL surface and an
increased adipocyte numbers (Figures S3C and S3D), confirmed
by the decreased Runx2 gene expression in flushed bone, and
increased adipogenic markers aP2, PPARg2, and leptin in BM
of mice receiving microbiota from HFD-treated mice (Figures
S3E and S3F).
Next, we depleted the microbiota of ND and HFD mice using
an antibiotics cocktail (four ATBs), which resulted in > 99.5%
reduction of intestinal bacteria (data not shown). Interestingly,
ATB treatment eliminated the difference in MSC, LSK, LT-LSK,
ST-LSK, myeloid progenitor, CLP populations, bone niche
markers, and leptin level in BM from ND and HFD mice (Figures
4A–4C, data not shown). It is noteworthy that there was an in-
crease of LSK, LT-LSK, and CLP population in ATB-treated ND
mice compared to ND vehicle group (Figures 4A and 4B),
suggesting that four ATBs could possibly directly affect HSC
differentiation. Therefore, we selectively deplete the microbiome
using vancomycin (VCM) targeting Gram-positive bacteria
(Lundstrom and Sobel, 2000). Indeed, VCM treatment led to a
strong depletion of Bacteroidetes, Firmicutes, and Actinobacte-
ria and increased abundance of Verrucomicrobia and Proteo-
bacteria (Figure 4D). Interestingly, VCM treatment induced a sig-
nificant decrease of LSK, LT-LSK, myeloid progenitor, and MSC
population in VCM-treated HFD mice compared to untreated
HFD mice (Figures 4E–4G). Although the increased tendency of
LSK in HFDmice was not completely eliminated after VCM treat-
ment, bone niche markers and leptin level were comparable in
HFD and ND BM (Figures 4E–4G, Figures S4A and S4B). The
bone volume, OBL, and adipocyte number were also rescued af-
ter VCM treatment (Figure S4C). To exclude a direct effect of
VCM on HSC, we transferred the stool from VCM-treated HFD
mice into HFD mice (Figure S4D). The stool transfer of VCM-
treated mice showed similar effect on MSC, LSK, MPP, and
CLP population as the direct VCM treatment (Figures S4E–
S4G), suggesting that the rescue of HFDmice by VCM is efficient
through HFD microbiota changes. Collectively, these dataor 6 weeks (n = 8).
R family genes (H) in CD45 cells from mice receiving HFD or ND for 6 weeks
01 were assessed using Student’s t test.
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Figure 3. HFD Affected Intestinal Microbiome, Responsible for the HSC Alteration
(A) Principle component analysis (PCA) of cecum and ileum samples from HFD or ND mice. Each point represents the microbiota of an individual mouse.
(B) Phylogenetic classification of 16S rRNA gene frequencies in the cecum and ileum content from mice receiving HFD or ND for 6 weeks.
(C and D) FACS plot (C) and FACS quantification (D) of LT-LSK, ST-LSK, and MPP cells in BM from mice after stool transplantation.
(E and F) FACS quantification of myeloid progenitor, CLP (E), and MSC (F) in BM from mice after stool transplantation (n = 8).
Data represent the mean ± SEM. See also Figure S3. *p < 0.05, **p < 0.01 were assessed using Student’s t test.indicated that Gram-positive bacteria depletion rescued the
HSC levels of the HFD mice.
DISCUSSION
Herein we demonstrate that HFD alters the bone microenviron-
ment and in consequence the HSC niche. This deterioration of
the HSC niche, formed by the osteoblastic lineage localized
in the endosteum, is characterized by the alteration of MSC,
OBL, and adipocyte number. Functionally, these alterations
appear to result from HFD-induced change in the Gram-positive
bacteria in the microbiome. Mechanistically, PPARg activity
plays a crucial role in this process since inhibition of PPARg
restored the number of OBLs and adipocytes altered by HFD,
thereby rescuing the disturbed HSC differentiation in BM.
Despite reports of immune dysregulation after HFD (Trottier
et al., 2012), the molecular mechanism of how metabolic stress
could affect the HSC niche and the development of immune cellsCell Mhas been unclear. HSCs either self-renew or differentiate into
restricted progenitors committed to the myeloid or lymphoid
lineage, able to build up blood cells and the immune system
(Rieger et al., 2009). Recent studies support the concept that
long-termHSCs residing next to the endosteal bone surface pro-
duce progenitors that migrate to blood vessels at the center of
BM cavity where they mature and further differentiate (Yin and
Li, 2006). Therefore, the decreased percentage of long-term
HSCs and the increased percentage of multipotent progenitors
observed in our model of HFD mice reflect the disturbance of
the endosteal HSC niche. Obviously, these changes also affect
immune cell lineage differentiation, as shown by the decrease
in B cell progenitors and CLPs, representing a shift from lympho-
poiesis to myelopoiesis. Not only was the HSC differentiation
altered by HFD, but also the hematologic recovery as shown
by our experiment with 5-FU.
HSC niche changes after HFD could depend on mediators
shaping the BM microenvironment, such as SDF-1, its receptoretabolism 22, 886–894, November 3, 2015 ª2015 Elsevier Inc. 891
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Figure 4. Vancomycin Treatment Rescues the HSC
Alteration
(A–C) FACS quantification of LSK, LT-LSK, ST-LSK (A),
myeloid progenitor, CLP (B), and MSC (C) in BM from
mice receiving HFD or ND mice treated or not with antibi-
otics (n = 8).
(D) Phylogenetic classification of 16S rRNA gene fre-
quencies in the cecum and ileum content from samples
collected frommice under HFD or ND for 6 weeks, untreated
or treated with vancomycin (VCM).
(E–G) FACS quantification of LSK, LT-LSK, ST-LSK (E),
myeloid progenitor, CLP (F), and MSC (G) in BM from mice
receiving HFD or ND, treated or not with VCM.
(H) Representative scheme of the effect of short-term HFD
on the bone niche through the microbiota (n = 8).
Data represent the mean ± SEM. See also Figure S4. *p <
0.05, **p < 0.01 were assessed using one-way ANOVA
followed by Bonferroni’s post hoc tests.
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CXCR4, SCF, vcam1, Ang-1/Tie2, Jag-1/Notch, and inter-
leukin-7 (Arai et al., 2004; Sugiyama and Nagasawa, 2012).
Interestingly, our data showed that HFD significantly decreased
the expression of SDF-1, Jag-1/Notch, and Tie2, which impairs
HSC maintenance. SDF-1, Notch, and Jag1 expressed by oste-
oblastic cells are considered key regulators of the HSC niches
(Yin and Li, 2006), which could influence the HSC mobilization
and differentiation from lymphopoiesis into myelopoiesis after
HFD. The lower OBL number combined with higher adipocyte
number in BM after HFD indicated that changes in mesen-
chymal stem cell (MSC) function guide the alterations found
in the HSC niche. Indeed, Ter119CD45Sca-1+ MSC number
was increased in BM of HFD mice. The commitment of these
cells toward adipocyte and osteoblast lineage occurs with the
activation of lineage-specific transcription factors, such as
Runx2 for OBL and PPARg for adipocytes (Ahmadian et al.,
2013; Komori, 2011). In addition, the increased adipocyte dif-
ferentiation in BM of HFD mice was associated with an
enhanced expression of PPARg affecting the balance of MSC
differentiation into adipocyte (Ding et al., 2012; Duque et al.,
2013; Wan, 2010; Zhou et al., 2014). Treatment with PPARg
antagonist BADGE, known to increase osteoblastogenesis but
decrease BM adiposity (Duque et al., 2013; Naveiras et al.,
2009), normalized PPARg2 and leptin levels and reversed the
altered balance between OBL and adipocyte in HFD-treated
mice in vivo. Therefore, leptin can possibly maintain MSC and
control lymphopoiesis and myelopoiesis in the HFD condition
(Claycombe et al., 2008; Fantuzzi and Faggioni, 2000). In
accordance, HSC and immune cells in the BM of mice exposed
to HFD completely normalized after PPARg antagonist treat-
ment. These data supported the hypothesis that PPARg plays
an essential role in the HFD-induced changes of HSC niche
and differentiation.
Obese mice and humans display low-grade inflammation and
microbiota alteration (Hotamisligil, 2006; Jee et al., 2006). In our
short-time HFD model, pro-inflammatory cytokine levels re-
mained unaltered in both serum and BM. Gut microbiota ana-
lyses showed a decrease in Bacteroidetes and Firmicutes and
an increase in Verrucomicrobia, Actinobacteria, and Proteobac-
teria in the cecum and ileum of the HFD mice, similar to previous
reports (Schwiertz et al., 2010; Zhang et al., 2012). However, the
levels of Bacteroidetes and Firmicutes in obese mice and human
are differently described in several reports, probably due to the
genetic background of the mice, the diet, the facility, and the
method of analyses (Ley et al., 2008; Turnbaugh et al., 2008).
Interestingly, HFD exposure altering the microbiota appears
to be an important step in mediating the effects of HFD on the
HSC phenotype since stool transplantation from HFD mice
transferred the HSC phenotype into normal mice. Furthermore,
the Gram-positive bacteria appear most relevant in the transfer
of the HSC phenotype, since their depletion by VCM also res-
cues the HSC phenotype observed in HFD mice (Hansen et al.,
2012). This finding adds an important role of the microbiota,
linking obesity to diseases such as type 2 diabetes (Cani et al.,
2008), asthma, and inflammatory bowel diseases (Hart and
Hendy, 2014).
In conclusion, our data showed that HFD leads to profound
changes of BM microenvironment through the alteration of
microbiota. HFD increased BM adiposity and induced a loss ofCell Mthe molecular properties of the endosteal HSC niche formed
by the osteoblastic lineage. These insights will open new possi-
bilities to impact BM and immune cell function by modulation of
microbiota.
EXPERIMENTAL PROCEDURES
Mice
Male C57BL/6 mice (5 weeks old) were purchased from Jackson Labs and
were acclimated for at least 1 week before study. Mice were fed with ND
(ssniff, Cat#D59494) or HFD (Research Diets, Cat# D12330) ad libitum for
6 weeks. Detailed information on diet is provided in Table S1 (see also Supple-
mental Experimental Procedures).
Flow Cytometry Analysis
BM cells were isolated by flushing the long bones with PBS. Splenocytes were
obtained by crushing the spleen and gently filtrated through a 70-mm cell
strainer. Blood cells were obtained by intracardiac puncture. After red blood
cell lysis, cells were stained with different antibodies for FACS analyses (see
Supplemental Experimental Procedures).
Next-Generation Sequencing
Fresh stools were collected from cecum and ileum of ND and HFD mice.
Bacterial genomic DNA from stools was isolated using a QIAamp DNA Stool
Mini Kit (QIAGEN). The V3+4 region of the 16S rRNA gene was amplified
using 10 ng of bacterial DNA with degenerate region-specific primers con-
taining barcodes and Illumina flow cell adaptor sequences as described
previously. Amplicons were gel purified, quantified using a Qbit device (Invi-
trogen), normalized, and pooled before sequencing on an Illumina miseq
device using a 600-cycle paired-end kit. Quality-controlled, demultiplexed
paired-end reads were classified using the RDPClassifier 2.10 (16S rRNA
training set 10) database, and results were analyzed using Megan5 and
Metagenassist.
Statistics
All data are presented as mean ± SEM. The statistical significance be-
tween two groups was determined by unpaired two-tailed Student’s t test.
Dataset involving more than two groups was assessed by one-way
ANOVA followed by Bonferroni’s post hoc test using GraphPad Prism (*p <
0.05, **p < 0.01).
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Supplemental Information includes Supplemental Experimental Procedures,
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